BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30541501)

  • 1. Conduct of vaccination in hard-to-reach areas to address potential polio reservoir areas, 2014-2015.
    Bawa S; Shuaib F; Saidu M; Ningi A; Abdullahi S; Abba B; Idowu A; Alkasim J; Hammanyero K; Warigon C; Tegegne SG; Banda R; Korir C; Yehualashet YG; Bedada T; Martin C; Nsubuga P; Adamu US; Okposen B; Braka F; Wondimagegnehu A; Vaz RG
    BMC Public Health; 2018 Dec; 18(Suppl 4):1312. PubMed ID: 30541501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learnt from implementing community engagement interventions in mobile hard-to-reach (HTR) projects in Nigeria, 2014-2015.
    Hammanyero KI; Bawa S; Braka F; Bassey BE; Fatiregun A; Warigon C; Yehualashet YG; Tegene SG; Banda R; Korir C; Erbeto TB; Chukwuji M; Mkanda P; Adamu US; Nsubuga P
    BMC Public Health; 2018 Dec; 18(Suppl 4):1306. PubMed ID: 30541514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the polio programme to deliver primary health care in Nigeria: implementation research.
    Bawa S; McNab C; Nkwogu L; Braka F; Obinya E; Galway M; Mirelman AJ; Hammanyero KI; Safiyanu G; Chukwuji M; Ongwae K; Mkanda P; Corkum M; Hegg L; Tollefson D; Umar S; Audu S; Gunda H; Chinta M; Jean Baptiste AE; Bagana M; Shuaib F
    Bull World Health Organ; 2019 Jan; 97(1):24-32. PubMed ID: 30618462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences from polio supplementary immunization activities in Anambra State, Nigeria.
    Onyeka IN; Ilika AL; Ilika FN; Umeh DC; Onyibe RI; Okoye CJ; Diden G; Onubogu CU
    Niger J Clin Pract; 2014; 17(6):808-13. PubMed ID: 25385924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region.
    Anya BM; Moturi E; Aschalew T; Carole Tevi-Benissan M; Akanmori BD; Poy AN; Mbulu KL; Okeibunor J; Mihigo R; Zawaira F
    Vaccine; 2016 Oct; 34(43):5187-5192. PubMed ID: 27396492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (DOPV) in northern Nigeria, (2014-2016).
    Korir C; Shuaib F; Adamu U; Bawa S; Musa A; Bashir A; Isiaka A; Ningi A; Warigon C; Richard B; Fiona B; Pascal M; Loveday N; Tegegne SG; Abdul-Aziz M; Suleiman A; Mohammed K; Corkum M; Onoka C; Nsubuga P; Yehualashet YG; Vaz RG; Alemu W
    BMC Public Health; 2018 Dec; 18(Suppl 4):1314. PubMed ID: 30541493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demand-side determinants of timely vaccination of oral polio vaccine in social mobilization network areas of CORE Group polio project in Uttar Pradesh, India.
    Choudhary M; Solomon R; Awale J; Dey R
    BMC Infect Dis; 2018 May; 18(1):222. PubMed ID: 29769034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polio field census and vaccination of underserved populations--northern Nigeria, 2012-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):663-5. PubMed ID: 23965829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transboundary nomadic population movement: a potential for import-export of poliovirus.
    Bawa S; Afolabi M; Abdelrahim K; Abba G; Ningi A; Tafida SY; Tegegne SG; Warigon C; Nomhwange T; Umar SA; Aregay A; Fanti A; Ahmed B; Nsubuga P; Adamu U; Braka F; Wondimagegnehu A; Shuaib F
    BMC Public Health; 2018 Dec; 18(Suppl 4):1316. PubMed ID: 30541502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revelation of an important weakness in polio elimination efforts in Nigeria: a descriptive cross-sectional study of nomadic dynamics in Sokoto and Taraba States, May 2013.
    Aliyu N; Bawa MK; Gidado S; Ohuabunwo C; Esapa L; Archer WR; Sule A; Bolatito HA; Mamman A; Olayinka A; Balogun MS; Getso KI; Dalhat MM; Haladu AS; Shehu UL; Nguku PM; Shehu A; Abdulganiyu S; Waziri NE
    Pan Afr Med J; 2021; 40(Suppl 1):12. PubMed ID: 36157561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
    Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014.
    Craig KT; Verma H; Iliyasu Z; Mkanda P; Touray K; Johnson T; Walla A; Banda R; Tegegne SG; Yehualashet YG; Abba B; Ahmad-Shehu A; Takane M; Sutter RW; Nsubuga P; Muhammad AJ; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S124-30. PubMed ID: 26908720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.
    Domingues CM; de Fátima Pereira S; Cunha Marreiros AC; Menezes N; Flannery B
    J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S143-51. PubMed ID: 25316829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.
    Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
    PLoS One; 2015; 10(6):e0130123. PubMed ID: 26068928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress Toward Poliomyelitis Eradication--Nigeria, January 2014-July 2015.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Ticha JM; Banda R; Korir C; Chevez AE; Enemaku O; Corkum M; Davis LB; Nganda GW; Burns CC; Wassilak SG; Vertefeuille JF
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(32):878-82. PubMed ID: 26292207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.